Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05960838

Ultrasling Quadrant Versus Bledsoe ARC Shoulder Brace

Evaluation of Functionality, Operability and Wearing Comfort of Two Multifunctional Shoulder Braces in Patients Who Underwent Shoulder Surgery

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Schulthess Klinik · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Shoulder orthoses are an essential component of both, postoperative care as well as a range of conservative treatment concepts, and thus influence the functional outcome of a wide spectrum of glenohumeral pathologies. Therefore it is important to look at them in greater detail. A new concept, designed by DJO Global in the "Ultrasling Quadrant®" orthosis now immobilizes only the glenohumeral joint, while giving the possibility of elbow movement. It also allows multiple settings concerning the position of the glenohumeral joint like internal rotation as well as neutral or external rotation. It is yet to be seen how these changes will influence the outcome of therapy as well as how they will change the patient's perception of the orthosis and its wearing comfort. Therefore it is planned to be compared to another multifunctional shoulder brace already established on the domestic and international market, the BledsoeARC® brace. The primary objective is to assess if one of the investigated shoulder braces Ultrasling Quadrant® or Bledsoe Arc® is perceived by patients who received shoulder surgery as superior in terms of higher wearing comfort when worn during the post-operative immobilization period.

Conditions

Interventions

TypeNameDescription
DEVICEUltrasling® QuadrantImmobilization with the Ultrasling® Quadrant (DJO Global Switzerland Sàrl, Ecublens, Switzerland) shoulder brace after surgical treatment
DEVICEBledsoe ARC®Immobilization with the Bledsoe ARC® (Breg Inc., Carlsbad, CA USA) brace after surgical treatment

Timeline

Start date
2026-01-01
Primary completion
2026-01-01
Completion
2028-01-01
First posted
2023-07-27
Last updated
2023-07-27

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05960838. Inclusion in this directory is not an endorsement.